Variant Annotationv0.1.0

A diagnostic lab uses the skill to annotate variants from patient sequencing data, providing clinical significance reports for hereditary cancer or rare disease panels. It helps classify variants as pathogenic, benign, or VUS to guide treatment decisions and genetic counseling.

Drug developers employ the skill to analyze genetic variants in clinical trial cohorts, identifying biomarkers for drug response or adverse events. It supports precision medicine by linking variants to disease mechanisms and population frequencies.

Researchers use the skill to annotate variants from genome-wide association studies (GWAS) or exome sequencing projects, integrating ClinVar and dbSNP data for publications. It aids in interpreting novel variants and assessing pathogenicity based on ACMG guidelines.

A consumer genetics company integrates the skill to provide users with detailed reports on their genetic variants, explaining clinical significance and disease risks. It enhances user engagement by offering actionable health insights from raw data.

A hospital's bioinformatics team incorporates the skill into their variant calling pipeline for oncology or cardiology patients, automating annotation to speed up diagnosis. It ensures consistent reporting using standardized databases and criteria.

Offer the skill as a cloud-based API with tiered pricing based on query volume, targeting labs and researchers. Revenue comes from monthly subscriptions and pay-per-use fees for high-throughput annotation needs.

Sell on-premise licenses to large institutions like hospitals or pharma companies, providing customization and integration support. Revenue is generated through upfront license fees and annual maintenance contracts.

Provide a free basic version for academic users with limited queries, while charging for advanced features like batch processing, ACMG scoring details, and priority support. Revenue comes from premium upgrades and consulting services.